Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Profiling circulating microRNA expression in a mouse model of nerve allotransplantation.

Rau CS, Yang JC, Wu SC, Chen YC, Lu TH, Lin MW, Wu YC, Tzeng SL, Wu CJ, Hsieh CH.

J Biomed Sci. 2013 Sep 5;20:64. doi: 10.1186/1423-0127-20-64.

2.

Identification of Circulating miRNAs in a Mouse Model of Nerve Allograft Transplantation under FK506 Immunosuppression by Illumina Small RNA Deep Sequencing.

Wu SC, Rau CS, Yang JC, Lu TH, Wu YC, Chen YC, Tzeng SL, Wu CJ, Lin CW, Hsieh CH.

Dis Markers. 2015;2015:863192. doi: 10.1155/2015/863192. Epub 2015 Sep 8.

3.

Effect of cold nerve allograft preservation on antigen presentation and rejection.

Ray WZ, Kale SS, Kasukurthi R, Papp EM, Johnson PJ, Santosa KB, Yan Y, Hunter DA, Mackinnon SE, Tung TH.

J Neurosurg. 2011 Jan;114(1):256-62. doi: 10.3171/2010.5.JNS10111. Epub 2010 Jun 18.

4.

Assessment of the immune response to dose of nerve allografts.

Sen SK, Lowe JB 3rd, Brenner MJ, Hunter DA, Mackinnon SE.

Plast Reconstr Surg. 2005 Mar;115(3):823-30.

PMID:
15731684
5.

RNA Profiling in Human and Murine Transplanted Hearts: Identification and Validation of Therapeutic Targets for Acute Cardiac and Renal Allograft Rejection.

Van Aelst LN, Summer G, Li S, Gupta SK, Heggermont W, De Vusser K, Carai P, Naesens M, Van Cleemput J, Van de Werf F, Vanhaecke J, Thum T, Waer M, Papageorgiou AP, Schroen B, Heymans S.

Am J Transplant. 2016 Jan;16(1):99-110. doi: 10.1111/ajt.13421. Epub 2015 Aug 6.

6.

Differential expression of microRNAs during allograft rejection.

Wei L, Wang M, Qu X, Mah A, Xiong X, Harris AG, Phillips LK, Martinez OM, Krams SM.

Am J Transplant. 2012 May;12(5):1113-23. doi: 10.1111/j.1600-6143.2011.03958.x. Epub 2012 Feb 2.

7.

The effects of rapamycin in murine peripheral nerve isografts and allografts.

Myckatyn TM, Ellis RA, Grand AG, Sen SK, Lowe JB 3rd, Hunter DA, Mackinnon SE.

Plast Reconstr Surg. 2002 Jun;109(7):2405-17.

PMID:
12045568
8.

Profiling circulating microRNA expression in experimental sepsis using cecal ligation and puncture.

Wu SC, Yang JC, Rau CS, Chen YC, Lu TH, Lin MW, Tzeng SL, Wu YC, Wu CJ, Hsieh CH.

PLoS One. 2013 Oct 30;8(10):e77936. doi: 10.1371/journal.pone.0077936. eCollection 2013.

9.

Anti-CD40L monoclonal antibody treatment induces long-term, tissue-specific, immunologic hyporesponsiveness to peripheral nerve allografts.

Mungara AK, Brown DL, Bishop DK, Wood SY, Cederna PS.

J Reconstr Microsurg. 2008 Apr;24(3):189-95. doi: 10.1055/s-2008-1076085. Epub 2008 Apr 5.

PMID:
18459087
10.

Endothelium-enriched microRNAs as diagnostic biomarkers for cardiac allograft vasculopathy.

Singh N, Heggermont W, Fieuws S, Vanhaecke J, Van Cleemput J, De Geest B.

J Heart Lung Transplant. 2015 Nov;34(11):1376-84. doi: 10.1016/j.healun.2015.06.008. Epub 2015 Jun 17.

PMID:
26198441
11.

MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA.

Scian MJ, Maluf DG, David KG, Archer KJ, Suh JL, Wolen AR, Mba MU, Massey HD, King AL, Gehr T, Cotterell A, Posner M, Mas V.

Am J Transplant. 2011 Oct;11(10):2110-22. doi: 10.1111/j.1600-6143.2011.03666.x. Epub 2011 Jul 27.

12.

MicroRNAs as non-invasive biomarkers of heart transplant rejection.

Duong Van Huyen JP, Tible M, Gay A, Guillemain R, Aubert O, Varnous S, Iserin F, Rouvier P, François A, Vernerey D, Loyer X, Leprince P, Empana JP, Bruneval P, Loupy A, Jouven X.

Eur Heart J. 2014 Dec 1;35(45):3194-202. doi: 10.1093/eurheartj/ehu346. Epub 2014 Aug 31.

PMID:
25176944
13.

Circulating microRNA profiles altered in mice after 28 d exposure to perfluorooctanoic acid.

Yan S, Wang J, Zhang W, Dai J.

Toxicol Lett. 2014 Jan 3;224(1):24-31.

PMID:
24459700
14.

miR-21 promotes fibrosis in an acute cardiac allograft transplantation model.

Gupta SK, Itagaki R, Zheng X, Batkai S, Thum S, Ahmad F, Van Aelst LN, Sharma A, Piccoli MT, Weinberger F, Fiedler J, Heuser M, Heymans S, Falk CS, Förster R, Schrepfer S, Thum T.

Cardiovasc Res. 2016 May 15;110(2):215-26. doi: 10.1093/cvr/cvw030. Epub 2016 Feb 9.

PMID:
26865549
15.
16.

FK506 and anti-CD40 ligand in peripheral nerve allotransplantation.

Brenner MJ, Mackinnon SE, Rickman SR, Jaramillo A, Tung TH, Hunter DA, Mohanakumar T.

Restor Neurol Neurosci. 2005;23(3-4):237-49.

PMID:
16082080
17.

microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.

Brunet Vega A, Pericay C, Moya I, Ferrer A, Dotor E, Pisa A, Casalots À, Serra-Aracil X, Oliva JC, Ruiz A, Saigí E.

Oncol Rep. 2013 Jul;30(1):320-6. doi: 10.3892/or.2013.2475. Epub 2013 May 15.

PMID:
23673725
18.

Targeting the circulating microRNA signature of obesity.

Ortega FJ, Mercader JM, Catalán V, Moreno-Navarrete JM, Pueyo N, Sabater M, Gómez-Ambrosi J, Anglada R, Fernández-Formoso JA, Ricart W, Frühbeck G, Fernández-Real JM.

Clin Chem. 2013 May;59(5):781-92. doi: 10.1373/clinchem.2012.195776. Epub 2013 Feb 8.

19.

Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.

Kodahl AR, Lyng MB, Binder H, Cold S, Gravgaard K, Knoop AS, Ditzel HJ.

Mol Oncol. 2014 Jul;8(5):874-83. doi: 10.1016/j.molonc.2014.03.002. Epub 2014 Mar 16.

20.

FK506 rescues peripheral nerve allografts in acute rejection.

Feng FY, Ogden MA, Myckatyn TM, Grand AG, Jensen JN, Hunter DA, Mackinnon SE.

J Neurotrauma. 2001 Feb;18(2):217-29.

PMID:
11229713

Supplemental Content

Support Center